NETHERTON SYNDROME
Clinical trials for NETHERTON SYNDROME explained in plain language.
Never miss a new study
Get alerted when new NETHERTON SYNDROME trials appear
Sign up with your email to follow new studies for NETHERTON SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hope for rare skin disease falls short: trial ends early
Disease control TerminatedThis study tested a medicine called spesolimab in people aged 12 and older with Netherton syndrome, a rare genetic skin condition causing redness and scaling. Participants received either the drug or a placebo for 4 months, then everyone could get the drug. The goal was to see if…
Matched conditions: NETHERTON SYNDROME
Phase: PHASE2, PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 17, 2026 20:22 UTC
-
Rare skin disease study aims to map its natural course
Knowledge-focused TerminatedThis study looked at people with Netherton Syndrome, a rare genetic skin condition, to track how the disease progresses naturally without any experimental treatment. Researchers measured skin redness and scaling using standard scores. The goal was to better understand the disease…
Matched conditions: NETHERTON SYNDROME
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC